Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GE HealthCare Technologies Inc. - Common Stock (NQ: GEHC )

83.00 +0.49 (+0.59%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about GE HealthCare Technologies Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
GE HealthCare unveils Pristina Via to streamline technologist workflow and improve patient-centered breast care
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare management to present at upcoming investor conferences
From GE HealthCare
Via Business Wire
GE HealthCare Announces Advanced Imaging Innovations for OEC 3D C-arm to Help Improve Precision Care in Practice of Interventional Pulmonology
From GE HealthCare
Via Business Wire
GE HealthCare hosts 2024 Investor Day: focus on innovation to deliver precision care and drive growth
From GE HealthCare
Via Business Wire
Pilot Study Showcases the Value of Portrait Mobile Continuous Monitoring Solution to Encourage Clinical Intervention While Mitigating Alarm Fatigue
From GE HealthCare
Via Business Wire
GE HealthCare Receives FDA Clearance for Head-Only SIGNA MAGNUS 3.0T MRI System
From GE HealthCare
Via Business Wire
GE HealthCare Announces Initiative to Help Address Radiologic Technologist Shortage
From GE HealthCare
Via Business Wire
How AI is Shaping the Future of Healthcare: Key Advances in Diagnostics and Precision Medicine
EQNX::TICKER_START (OTCQB:AVAI),(NYSE:BFLY),(NASDAQ:TEM),(NASDAQ:GEHC),(NASDAQ:RDNT) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare Technologies Inc. Prices Secondary Offering of 13,281,302 Shares
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare Technologies Inc. Commences Secondary Offering of 13,281,302 Shares
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare to Host its 2024 Investor Day on November 21
From GE HealthCare
Via Business Wire
GE HealthCare reports third quarter 2024 financial results
From GE HealthCare
Via Business Wire
GE HealthCare Announces AI Innovation Lab Showcasing Five New Research Projects
From GE HealthCare
Via Business Wire
GE HealthCare announces CareIntellect for Oncology, harnessing AI to give clinicians an easy way to see the patient journey in a single view
From GE HealthCare
Via Business Wire
GE HealthCare, the GE HealthCare Foundation, and the Charles Antetokounmpo Family Foundation commit $1M to improve Milwaukee health outcomes
From GE HealthCare
Via Business Wire
GE HealthCare announces major academic medical center as first customer to adopt new Hospital Pulse Tile for Command Center
From GE HealthCare Technologies Inc.
Via Business Wire
A New Theranostics Center of Excellence in Europe: GE HealthCare and University Medicine Essen Collaborate to Advance Theranostics and Personalized Medicine
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare introduces easy-to-use, easy-to-learn, easy-to-diagnose Versana Premier multi-purpose ultrasound system
From GE HealthCare
Via Business Wire
GE HealthCare Accelerates Artificial Intelligence Adoption With New Offering to Advance Enterprise Imaging
From GE HealthCare
Via Business Wire
GE HealthCare to announce third quarter 2024 results on October 30, 2024
From GE HealthCare
Via Business Wire
GE HealthCare takes key role in new consortium to revolutionize cancer care, advancing precision medicine for patients in Europe
From GE HealthCare
Via Business Wire
GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
From GE HealthCare
Via Business Wire
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare Showcases the Latest AI-enhanced Radiation Therapy Solutions at ASTRO 2024
From GE HealthCare
Via Business Wire
GE HealthCare introduces elevated Venue point of care ultrasound solutions and new tablet-based Venue Sprint
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare announces cash dividend for third quarter of 2024
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare Technologies Inc. Prices Upsized Secondary Offering of 15,000,000 Shares
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare Technologies Inc. Commences Secondary Offering of 10,000,000 Shares
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare Showcases Latest AI-Enhanced Cardiology Solutions to Enable Real-Time Cardiac Imaging and Assessments at the Point of Care at ESC 2024
From GE HealthCare
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.